Skip to content
10-K

Annual Report

Zander Therapeutics, Inc

0001607062-19-000354

← back to feed
Filed
Aug 30, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Aug 14, 2019 6.58M sh
Operating Cash Flow FY 2019 · Jun 30, 2019 −$1.2M
Operating Cash Flow restated FY 2019 · Jun 30, 2018 −$1.11M
Cash And Equivalents FY 2019 · Jun 30, 2019 $28.12K
Cash And Equivalents FY 2019 · Jun 30, 2018 $370.31K
Cash And Equivalents FY 2019 · Jun 30, 2017 $96.01K
Stockholders Equity FY 2019 · Jun 30, 2019 $768.06K
Stockholders Equity restated FY 2019 · Jun 30, 2018 −$627.36K
Stockholders Equity FY 2019 · Jun 30, 2017 −$131.24K
Current Liabilities FY 2019 · Jun 30, 2019 $1.9M
Current Liabilities FY 2019 · Jun 30, 2018 $1.1M
Total Liabilities FY 2019 · Jun 30, 2019 $1.9M
Total Liabilities FY 2019 · Jun 30, 2018 $1.1M
Current Assets FY 2019 · Jun 30, 2019 $185.07K
Current Assets FY 2019 · Jun 30, 2018 $472.2K
Total Assets FY 2019 · Jun 30, 2019 $2.67M
Total Assets FY 2019 · Jun 30, 2018 $472.2K
Sga Expense FY 2019 · Jun 30, 2019 $780.88K
Sga Expense FY 2019 · Jun 30, 2018 $135.7K
Rd Expense FY 2019 · Jun 30, 2019 $574.4K
Rd Expense FY 2019 · Jun 30, 2018 $1.67M
Net Income FY 2019 · Jun 30, 2019 $308.52K
Net Income FY 2019 · Jun 30, 2018 −$2.18M
Operating Income FY 2019 · Jun 30, 2019 −$1.79M
Operating Income FY 2019 · Jun 30, 2018 −$2.17M